Main competitors
Dividend Yield (N) Dividend Yield (N+1) P/E (N) Price to Book (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Capi.($)
- - - - - - - 11Cr
0.75%0.84%37.01x26.72x12.23x27.9x30.03x 71TCr
3.36%3.45%14.98x5.08x4.17x11.47x12.76x 38TCr
3.44%3.6%27.01x46.72x6.54x13.6x14.08x 34TCr
2.98%3.47%16.99x9.6x6.13x12.24x13.52x 31TCr
3.79%3.89%14.32x5.45x3.51x8.7x9.98x 26TCr
3.21%3.36%17.39x5.18x4.7x11.37x12.43x 24TCr
2.28%2.4%22.25x4.84x4.15x12.2x12.95x 22TCr
3.84%4.04%10.73x3.81x3.48x7.5x8.36x 21TCr
3.23%3.4%22.55x17.65x5.8x11.25x13.15x 16TCr
6.68%6.82%12.08x1.6x2.94x7.28x8.43x 15TCr
2.87%3%20.8x6.24x5.3x9.7x11.69x 14TCr
-.--%-.--%31.85x6.22x9.5x19.99x21x 12TCr
4.97%5.24%11.67x1.29x2.42x7.91x8.63x 12TCr
5.2%5.38%10.73x4.69x2.81x7.38x7.89x 9.7TCr
4.56%4.86%9.98x3.92x2.21x6.53x7.48x 7.83TCr
3.7%1.74%25.69x5.59x8.53x16.78x17.56x 7.64TCr
0.41%0.46%50.09x6.82x11.04x40.41x44.11x 5.31TCr
4.51%4.6%28.45x1.02x2.36x8.7x21.95x 4.77TCr
Average 3.32% 3.36% 21.37x 9.03x 5.43x 13.38x 15.33x 19.46TCr
Weighted average by Cap. 2.92% 3.04% 22.32x 13.64x 6.31x 14.69x 16.16x
Other Pharmaceuticals